Citation
Serious Infection in Inflammatory Bowel Diseases Patients Treated With Vedolizumab, Ustekinumab, Janus Kinase Inhibitors, Anti–Tumor Necrosis Factor or Aminosalicylates. // Clinical Gastroenterology and Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S1542356526003186?dgcid=rss_sd_all
Serious Infection in Inflammatory Bowel Diseases Patients Treated With Vedolizumab, Ustekinumab, Janus Kinase Inhibitors, Anti–Tumor Necrosis Factor or Aminosalicylates. Clinical Gastroenterology and Hepatology. https://www.sciencedirect.com/science/article/pii/S1542356526003186?dgcid=rss_sd_all
“Serious Infection in Inflammatory Bowel Diseases Patients Treated With Vedolizumab, Ustekinumab, Janus Kinase Inhibitors, Anti–Tumor Necrosis Factor or Aminosalicylates.” Clinical Gastroenterology and Hepatology.
@article{article41144,
title = {Serious Infection in Inflammatory Bowel Diseases Patients Treated With Vedolizumab, Ustekinumab, Janus Kinase Inhibitors, Anti–Tumor Necrosis Factor or Aminosalicylates},
journal = {Clinical Gastroenterology and Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S1542356526003186?dgcid=rss_sd_all}
}